Basilea Pharmaceutica Ltd (0QNA) Forecast & Analyst Ratings

LSE

Currency in CHF

65.80

+0.50 (+0.77%)

Closed

Oct 7, 2026

Day's Range

64.50

66.00

52 wk Range

44.70

70.40

Date	Firm	Action	Rating
Oct 25, 2021	Wells Fargo	Maintains	Overweight
Aug 09, 2021	Wells Fargo	Maintains	Overweight
Mar 25, 2020	Wells Fargo	Maintains	Overweight
Nov 04, 2019	Wells Fargo	Upgrade	Market Perform → Outperform
Jan 16, 2019	JP Morgan	Downgrade	Neutral → Underweight
Nov 05, 2018	JP Morgan	Downgrade	Overweight → Neutral
Oct 04, 2018	Wells Fargo	Maintains	Market Perform
Feb 06, 2018	JP Morgan	Upgrade	Neutral → Overweight
Nov 01, 2017	JP Morgan	Maintains	Neutral
Jun 14, 2016	Citigroup	Maintains	Neutral

Items per row:

1-10 of 27

Current year · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

Period	Analysts	Low	Average	High	Year ago
Current quarter	-	-	-	-	-
Next quarter	0	0.00	0.00	0.00	-
Current year	-	-	-	-	-
Next year	-	-	-	-	-

Date	Time	EPS Estimate	EPS Actual	Difference	Surprise PRC
2026-07-14	After Hours	0.11	0.14	+0.03	‪+27.27%‬
2026-06-23	After Hours	0.76	0.74	-0.02	‪-2.63%‬
2026-05-04	After Hours	0.78	0.87	+0.09	‪+11.54%‬
2026-04-14	After Hours	0.44	0.48	+0.04	‪+9.09%‬
2026-03-30	After Hours	-0.65	-0.68	-0.03	‪+4.62%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated: Oct 7, 2026, 07:00 AM

App Store